Evaluation of Chemotherapy (Carboplatin) Dosing with Contrast Agent, IohexolResearch Question:
How well does iohexol, a contrast agent, work in helping doctors calculate the dose
of carboplatin given to patients with cancer?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This trial studies how well iohexol, a contrast agent, works in helping doctors calculate
the dose of carboplatin given to patients with cancer. A contrast agent is a substance
used to increase the contrast of structures or fluids within the body in medical imaging.
Drugs used in chemotherapy, such as carboplatin, work in different ways to stop the
growth of tumor cells, either by killing the cells, by stopping them from dividing,
or by stopping them from spreading. Understanding how to best calculate the dose of
carboplatin given to patients with cancer may help doctors learn how to improve the
use of carboplatin in the future.
Study Reference #: CMLT20003
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Barbara Kavinsky
Phone: (585) 273-3602
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search